Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis | 7 | 2023 | 1087 | 1.690 |
Why?
|
Gastrointestinal Hemorrhage | 13 | 2021 | 1127 | 1.640 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 7 | 2023 | 520 | 1.430 |
Why?
|
Intestinal Polyposis | 3 | 2021 | 42 | 1.030 |
Why?
|
Esophagitis | 8 | 2008 | 163 | 1.010 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2022 | 220 | 0.870 |
Why?
|
Endoscopy, Gastrointestinal | 9 | 2024 | 888 | 0.800 |
Why?
|
Eosinophilia | 7 | 2008 | 556 | 0.770 |
Why?
|
Gastrointestinal Diseases | 8 | 2018 | 1203 | 0.730 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2021 | 248 | 0.690 |
Why?
|
Capsule Endoscopy | 2 | 2019 | 107 | 0.680 |
Why?
|
Propofol | 2 | 2021 | 606 | 0.680 |
Why?
|
Esophageal and Gastric Varices | 2 | 2019 | 215 | 0.670 |
Why?
|
Deep Sedation | 1 | 2021 | 118 | 0.670 |
Why?
|
Colonic Polyps | 2 | 2022 | 556 | 0.610 |
Why?
|
Esophagus | 7 | 2018 | 1037 | 0.590 |
Why?
|
Hypertension, Portal | 1 | 2019 | 229 | 0.560 |
Why?
|
Dexmedetomidine | 1 | 2021 | 316 | 0.540 |
Why?
|
Rhabdomyosarcoma | 1 | 2018 | 354 | 0.480 |
Why?
|
Pluripotent Stem Cells | 4 | 2013 | 807 | 0.470 |
Why?
|
Embryonic Stem Cells | 6 | 2013 | 1241 | 0.460 |
Why?
|
Vascular Malformations | 2 | 2018 | 471 | 0.450 |
Why?
|
Eosinophils | 4 | 2008 | 945 | 0.430 |
Why?
|
Analgesia | 1 | 2018 | 461 | 0.420 |
Why?
|
Child | 52 | 2024 | 80563 | 0.410 |
Why?
|
Conscious Sedation | 2 | 2008 | 531 | 0.400 |
Why?
|
Sirolimus | 1 | 2019 | 1545 | 0.390 |
Why?
|
Endoscopy | 3 | 2017 | 1841 | 0.370 |
Why?
|
Analgesics | 1 | 2018 | 1060 | 0.360 |
Why?
|
Glass | 1 | 2011 | 116 | 0.350 |
Why?
|
Nevus, Blue | 3 | 2005 | 45 | 0.350 |
Why?
|
Arteriovenous Malformations | 2 | 2005 | 397 | 0.340 |
Why?
|
Gastroscopy | 2 | 2005 | 213 | 0.340 |
Why?
|
Hemangioma | 5 | 2018 | 723 | 0.310 |
Why?
|
Endosonography | 3 | 2017 | 626 | 0.290 |
Why?
|
Child, Preschool | 31 | 2024 | 42500 | 0.290 |
Why?
|
Cell Culture Techniques | 3 | 2013 | 1652 | 0.280 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4209 | 0.260 |
Why?
|
Midazolam | 1 | 2008 | 267 | 0.260 |
Why?
|
Barrett Esophagus | 2 | 2020 | 494 | 0.260 |
Why?
|
Capnography | 1 | 2006 | 90 | 0.250 |
Why?
|
Cautery | 1 | 2005 | 73 | 0.240 |
Why?
|
Cutaneous Fistula | 1 | 2005 | 80 | 0.240 |
Why?
|
Duodenoscopes | 2 | 2022 | 43 | 0.240 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2006 | 166 | 0.240 |
Why?
|
Gastric Fistula | 1 | 2005 | 73 | 0.230 |
Why?
|
Fentanyl | 1 | 2008 | 457 | 0.230 |
Why?
|
Esophagoscopy | 4 | 2003 | 398 | 0.230 |
Why?
|
Adolescent | 30 | 2022 | 88832 | 0.230 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2015 | 961 | 0.220 |
Why?
|
Receptors, Notch | 1 | 2007 | 752 | 0.210 |
Why?
|
Duodenum | 2 | 2004 | 495 | 0.210 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2002 | 40 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6942 | 0.200 |
Why?
|
Colectomy | 3 | 2022 | 697 | 0.200 |
Why?
|
Choledochal Cyst | 1 | 2022 | 25 | 0.190 |
Why?
|
Digestive System Abnormalities | 1 | 2001 | 49 | 0.190 |
Why?
|
Thoracoscopy | 2 | 2018 | 182 | 0.190 |
Why?
|
Abdominal Pain | 2 | 2018 | 1069 | 0.190 |
Why?
|
Esophageal Achalasia | 2 | 2018 | 99 | 0.180 |
Why?
|
Intestines | 3 | 2009 | 1906 | 0.180 |
Why?
|
Humans | 79 | 2024 | 765956 | 0.180 |
Why?
|
Short Bowel Syndrome | 1 | 2024 | 352 | 0.180 |
Why?
|
Cell Communication | 1 | 2007 | 1660 | 0.170 |
Why?
|
Syndrome | 3 | 2022 | 3271 | 0.170 |
Why?
|
Gallbladder | 1 | 2022 | 308 | 0.170 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5444 | 0.170 |
Why?
|
Pediatrics | 4 | 2017 | 3606 | 0.170 |
Why?
|
Gastrostomy | 2 | 2005 | 327 | 0.160 |
Why?
|
Pancreatic Diseases | 2 | 2017 | 353 | 0.150 |
Why?
|
Maple Syrup Urine Disease | 1 | 2018 | 41 | 0.150 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 2531 | 0.150 |
Why?
|
Endoscopy, Digestive System | 2 | 1998 | 358 | 0.150 |
Why?
|
Stomach | 1 | 2002 | 699 | 0.150 |
Why?
|
Infant | 18 | 2024 | 36385 | 0.150 |
Why?
|
Gastroesophageal Reflux | 4 | 2020 | 833 | 0.140 |
Why?
|
Retrospective Studies | 16 | 2024 | 81515 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4034 | 0.140 |
Why?
|
Catheterization | 1 | 2022 | 1425 | 0.140 |
Why?
|
Colonoscopy | 2 | 2022 | 1406 | 0.140 |
Why?
|
Portal Vein | 2 | 2010 | 435 | 0.140 |
Why?
|
Female | 44 | 2024 | 396101 | 0.130 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2017 | 101 | 0.130 |
Why?
|
Hemostasis, Surgical | 1 | 1996 | 127 | 0.130 |
Why?
|
Cell Differentiation | 4 | 2013 | 11640 | 0.120 |
Why?
|
Pancreas | 2 | 2017 | 1700 | 0.120 |
Why?
|
Intestine, Small | 2 | 2024 | 1214 | 0.120 |
Why?
|
Acute Disease | 3 | 2023 | 7232 | 0.120 |
Why?
|
Rectum | 3 | 2010 | 896 | 0.120 |
Why?
|
Prospective Studies | 9 | 2022 | 54806 | 0.120 |
Why?
|
Esophagitis, Peptic | 2 | 2006 | 77 | 0.120 |
Why?
|
Cell Lineage | 1 | 2003 | 2573 | 0.120 |
Why?
|
Thyroid Nodule | 1 | 2022 | 779 | 0.120 |
Why?
|
Male | 39 | 2024 | 363691 | 0.110 |
Why?
|
Embryoid Bodies | 1 | 2013 | 64 | 0.110 |
Why?
|
Surface Properties | 2 | 2011 | 1151 | 0.110 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2014 | 116 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1191 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2024 | 5302 | 0.100 |
Why?
|
Polyglycolic Acid | 1 | 2013 | 406 | 0.100 |
Why?
|
Skin Neoplasms | 4 | 2015 | 5849 | 0.100 |
Why?
|
Diagnosis, Differential | 6 | 2018 | 12976 | 0.100 |
Why?
|
Embryo, Mammalian | 2 | 2011 | 1673 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39194 | 0.090 |
Why?
|
Culture Media, Serum-Free | 1 | 2011 | 148 | 0.090 |
Why?
|
Adult | 15 | 2022 | 223038 | 0.090 |
Why?
|
Colony-Forming Units Assay | 1 | 2011 | 351 | 0.090 |
Why?
|
Stem Cell Niche | 1 | 2013 | 346 | 0.090 |
Why?
|
Acids | 1 | 2011 | 125 | 0.090 |
Why?
|
bcl-X Protein | 1 | 2011 | 414 | 0.080 |
Why?
|
Sterilization | 1 | 2011 | 133 | 0.080 |
Why?
|
Matrix Metalloproteinase 2 | 2 | 2009 | 462 | 0.080 |
Why?
|
Mesenteric Veins | 1 | 2010 | 86 | 0.080 |
Why?
|
Growth | 1 | 2011 | 365 | 0.080 |
Why?
|
Deoxyribonucleases | 1 | 2011 | 209 | 0.080 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1989 | 40 | 0.080 |
Why?
|
Infant, Newborn | 9 | 2017 | 26349 | 0.080 |
Why?
|
Biopsy | 3 | 2020 | 6763 | 0.080 |
Why?
|
Metaplasia | 2 | 2020 | 326 | 0.080 |
Why?
|
Signal Transduction | 2 | 2013 | 23600 | 0.080 |
Why?
|
Veins | 2 | 2006 | 764 | 0.080 |
Why?
|
Ligation | 3 | 2010 | 444 | 0.080 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2009 | 636 | 0.080 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 491 | 0.080 |
Why?
|
Lactic Acid | 1 | 2013 | 1137 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2022 | 2371 | 0.080 |
Why?
|
Deglutition Disorders | 3 | 2004 | 639 | 0.080 |
Why?
|
Fluoroscopy | 2 | 2023 | 947 | 0.070 |
Why?
|
Esophagogastric Junction | 2 | 2020 | 351 | 0.070 |
Why?
|
Carcinoma, Embryonal | 1 | 2007 | 36 | 0.070 |
Why?
|
Lymphatic Abnormalities | 1 | 2009 | 134 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4893 | 0.070 |
Why?
|
Anesthesia Recovery Period | 1 | 2008 | 155 | 0.070 |
Why?
|
Colon | 2 | 2009 | 1795 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2013 | 934 | 0.070 |
Why?
|
Protein Transport | 2 | 2013 | 1938 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2535 | 0.070 |
Why?
|
Liver | 3 | 2003 | 7562 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2226 | 0.060 |
Why?
|
Lymphangioma | 1 | 2006 | 60 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 392 | 0.060 |
Why?
|
Angiomatosis | 1 | 2005 | 45 | 0.060 |
Why?
|
Ambulatory Care | 1 | 1996 | 2778 | 0.060 |
Why?
|
Anesthetics, Intravenous | 1 | 2008 | 397 | 0.060 |
Why?
|
Phosphoproteins | 1 | 2013 | 2446 | 0.060 |
Why?
|
Embolism, Air | 1 | 2005 | 111 | 0.060 |
Why?
|
Health Policy | 1 | 1996 | 2698 | 0.060 |
Why?
|
Sampling Studies | 1 | 2005 | 607 | 0.060 |
Why?
|
Cholanes | 1 | 2003 | 1 | 0.060 |
Why?
|
Genetic Testing | 2 | 2014 | 3595 | 0.060 |
Why?
|
Hospitals, Pediatric | 2 | 2015 | 1846 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2019 | 65189 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2011 | 18973 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1991 | 2570 | 0.050 |
Why?
|
Endoscopes, Gastrointestinal | 2 | 2002 | 45 | 0.050 |
Why?
|
Atrioventricular Node | 1 | 2004 | 180 | 0.050 |
Why?
|
Foreign Bodies | 1 | 2008 | 402 | 0.050 |
Why?
|
Antigens, Surface | 1 | 2007 | 1617 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 2899 | 0.050 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 2229 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2008 | 1158 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11206 | 0.050 |
Why?
|
Recurrence | 3 | 2010 | 8501 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1874 | 0.050 |
Why?
|
Epoxide Hydrolases | 1 | 2003 | 121 | 0.050 |
Why?
|
Omeprazole | 1 | 2023 | 106 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2475 | 0.050 |
Why?
|
Incidence | 4 | 2010 | 21480 | 0.050 |
Why?
|
Heart Block | 1 | 2004 | 391 | 0.050 |
Why?
|
Cardia | 1 | 2002 | 61 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 2 | 2021 | 1119 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2845 | 0.050 |
Why?
|
Gastric Mucosa | 2 | 2022 | 602 | 0.050 |
Why?
|
Clinical Competence | 1 | 1998 | 4863 | 0.050 |
Why?
|
Length of Stay | 3 | 2018 | 6485 | 0.050 |
Why?
|
Cell Survival | 2 | 2010 | 5746 | 0.050 |
Why?
|
Parenteral Nutrition, Total | 1 | 2002 | 304 | 0.050 |
Why?
|
Ubiquinone | 1 | 2002 | 181 | 0.050 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2021 | 97 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2003 | 398 | 0.050 |
Why?
|
Intraoperative Complications | 2 | 2005 | 1162 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3750 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1327 | 0.040 |
Why?
|
Monitoring, Physiologic | 2 | 2006 | 1792 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 2010 | 1403 | 0.040 |
Why?
|
Young Adult | 4 | 2023 | 59886 | 0.040 |
Why?
|
Androstadienes | 1 | 2002 | 347 | 0.040 |
Why?
|
Device Removal | 1 | 2005 | 646 | 0.040 |
Why?
|
Fibroblasts | 1 | 2011 | 4159 | 0.040 |
Why?
|
Ischemia | 1 | 2009 | 1909 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2004 | 881 | 0.040 |
Why?
|
North America | 2 | 2002 | 1285 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2011 | 1883 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 1957 | 0.040 |
Why?
|
Dicloxacillin | 1 | 1979 | 9 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20660 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8529 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2011 | 2536 | 0.040 |
Why?
|
Biliary Tract Diseases | 1 | 2000 | 160 | 0.040 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 1998 | 49 | 0.040 |
Why?
|
Cell Line | 5 | 2013 | 15543 | 0.040 |
Why?
|
Mitochondrial Myopathies | 1 | 1998 | 49 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7875 | 0.040 |
Why?
|
Point Mutation | 1 | 2003 | 1590 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5876 | 0.040 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 1997 | 26 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1171 | 0.040 |
Why?
|
Gastroscopes | 1 | 1997 | 20 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 3715 | 0.030 |
Why?
|
Octreotide | 1 | 1998 | 157 | 0.030 |
Why?
|
Dilatation | 1 | 2018 | 310 | 0.030 |
Why?
|
Skin Diseases | 1 | 2005 | 1088 | 0.030 |
Why?
|
Biliary Atresia | 1 | 1997 | 87 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4475 | 0.030 |
Why?
|
Mice | 4 | 2013 | 81818 | 0.030 |
Why?
|
Melena | 1 | 2015 | 32 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10729 | 0.030 |
Why?
|
Abdomen | 1 | 2022 | 1134 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2010 | 10429 | 0.030 |
Why?
|
Animals | 7 | 2013 | 168759 | 0.030 |
Why?
|
Hemangioma, Cavernous | 1 | 2015 | 105 | 0.030 |
Why?
|
Cellulitis | 1 | 1997 | 206 | 0.030 |
Why?
|
Mesentery | 1 | 2015 | 199 | 0.030 |
Why?
|
Sex Distribution | 1 | 2000 | 2263 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2004 | 1490 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12057 | 0.030 |
Why?
|
Facial Neoplasms | 1 | 2015 | 127 | 0.030 |
Why?
|
Anticoagulants | 1 | 2010 | 4862 | 0.030 |
Why?
|
Certification | 1 | 1998 | 416 | 0.030 |
Why?
|
Gastroenterology | 2 | 2002 | 594 | 0.030 |
Why?
|
Symporters | 1 | 1997 | 362 | 0.030 |
Why?
|
Wound Healing | 1 | 2005 | 2792 | 0.030 |
Why?
|
Catheters, Indwelling | 1 | 1997 | 438 | 0.030 |
Why?
|
Equipment Failure | 1 | 1997 | 578 | 0.030 |
Why?
|
Age Distribution | 1 | 2000 | 2858 | 0.030 |
Why?
|
Vitamins | 1 | 2002 | 1630 | 0.030 |
Why?
|
Esophageal Diseases | 1 | 1995 | 166 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2008 | 2429 | 0.030 |
Why?
|
Sclerotherapy | 1 | 1995 | 184 | 0.030 |
Why?
|
Ulcer | 1 | 1995 | 201 | 0.030 |
Why?
|
Research | 1 | 2002 | 1975 | 0.030 |
Why?
|
Gastrointestinal Agents | 1 | 1998 | 510 | 0.030 |
Why?
|
Epinephrine | 1 | 1996 | 783 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 17075 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2002 | 1808 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2056 | 0.020 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2011 | 47 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2006 | 12437 | 0.020 |
Why?
|
Equipment Design | 1 | 2000 | 3481 | 0.020 |
Why?
|
Apoptosis | 1 | 2007 | 9514 | 0.020 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2011 | 127 | 0.020 |
Why?
|
Arteries | 1 | 1996 | 1118 | 0.020 |
Why?
|
Lung | 2 | 2009 | 10033 | 0.020 |
Why?
|
Confidence Intervals | 1 | 1997 | 2910 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2007 | 9249 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 1997 | 803 | 0.020 |
Why?
|
Forecasting | 1 | 2000 | 2936 | 0.020 |
Why?
|
Radiography | 3 | 2009 | 6919 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 1997 | 3432 | 0.020 |
Why?
|
Chronic Disease | 1 | 2005 | 9347 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 595 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2011 | 5881 | 0.020 |
Why?
|
Laparoscopy | 1 | 2001 | 2039 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2013 | 1524 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2013 | 1752 | 0.020 |
Why?
|
Hypersensitivity | 1 | 1999 | 1168 | 0.020 |
Why?
|
Cosmids | 1 | 1989 | 105 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2008 | 22222 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1599 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 2015 | 703 | 0.020 |
Why?
|
Phlebography | 1 | 2010 | 328 | 0.020 |
Why?
|
Societies, Medical | 2 | 2002 | 3956 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2011 | 576 | 0.020 |
Why?
|
Restriction Mapping | 1 | 1989 | 848 | 0.020 |
Why?
|
Rhinovirus | 1 | 1970 | 210 | 0.020 |
Why?
|
DNA Probes | 1 | 1989 | 541 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1997 | 2203 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2011 | 898 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10850 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3586 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2015 | 1050 | 0.020 |
Why?
|
Gene Targeting | 1 | 2011 | 841 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 1997 | 1543 | 0.020 |
Why?
|
Transgenes | 1 | 2011 | 1015 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41647 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3343 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2011 | 878 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1989 | 353 | 0.020 |
Why?
|
Reoperation | 1 | 1997 | 4294 | 0.020 |
Why?
|
Time Factors | 1 | 2008 | 40065 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14652 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 2002 | 10261 | 0.020 |
Why?
|
Anemia | 1 | 2015 | 1511 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1823 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 2 | 2006 | 2056 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2014 | 1519 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1996 | 3046 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 2832 | 0.020 |
Why?
|
Odds Ratio | 1 | 1997 | 9649 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4258 | 0.010 |
Why?
|
Hemorrhage | 1 | 1996 | 3461 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1997 | 4913 | 0.010 |
Why?
|
Risk Assessment | 1 | 2005 | 24283 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2013 | 1855 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4562 | 0.010 |
Why?
|
Genotype | 2 | 2011 | 13024 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2003 | 64 | 0.010 |
Why?
|
Pilot Projects | 2 | 2009 | 8733 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3089 | 0.010 |
Why?
|
Celiac Disease | 1 | 1991 | 820 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10808 | 0.010 |
Why?
|
Sports | 1 | 2009 | 698 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2003 | 295 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1995 | 2412 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9338 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2005 | 1701 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4908 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1546 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2004 | 582 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2011 | 3404 | 0.010 |
Why?
|
Risk Factors | 2 | 2000 | 74836 | 0.010 |
Why?
|
Electric Countershock | 1 | 2004 | 534 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26313 | 0.010 |
Why?
|
Introns | 1 | 2003 | 966 | 0.010 |
Why?
|
Fundoplication | 1 | 2001 | 146 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1588 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2011 | 3606 | 0.010 |
Why?
|
Gastritis | 1 | 2002 | 200 | 0.010 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2002 | 292 | 0.010 |
Why?
|
Transcription Factors | 2 | 2013 | 12131 | 0.010 |
Why?
|
Antigens, CD1 | 1 | 2002 | 435 | 0.010 |
Why?
|
Prognosis | 1 | 2000 | 29921 | 0.010 |
Why?
|
Methicillin | 1 | 1979 | 61 | 0.010 |
Why?
|
Rectal Diseases | 1 | 2000 | 141 | 0.010 |
Why?
|
Colonic Diseases | 1 | 2000 | 204 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4873 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2108 | 0.010 |
Why?
|
Mutation | 2 | 2013 | 30196 | 0.010 |
Why?
|
Epithelium | 1 | 2002 | 1599 | 0.010 |
Why?
|
DNA Methylation | 1 | 2011 | 4424 | 0.010 |
Why?
|
Sequence Analysis | 1 | 1997 | 239 | 0.010 |
Why?
|
Genetic Variation | 1 | 2011 | 6610 | 0.010 |
Why?
|
Neoplasms | 2 | 2013 | 22340 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2008 | 1915 | 0.010 |
Why?
|
Contrast Media | 1 | 2009 | 5329 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2005 | 2132 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5020 | 0.010 |
Why?
|
Crohn Disease | 1 | 2008 | 2283 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2003 | 12769 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11022 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2548 | 0.010 |
Why?
|
Osteomyelitis | 1 | 1979 | 408 | 0.010 |
Why?
|
Antigens, CD | 1 | 2005 | 4025 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6001 | 0.010 |
Why?
|
Mental Disorders | 1 | 2014 | 6851 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1999 | 2477 | 0.010 |
Why?
|
Cholestasis | 1 | 1997 | 386 | 0.010 |
Why?
|
Muscles | 1 | 1998 | 1578 | 0.010 |
Why?
|
HIV-1 | 1 | 2011 | 6944 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 1998 | 869 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2003 | 11888 | 0.010 |
Why?
|
Alleles | 1 | 2003 | 6897 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 16047 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5786 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15398 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1998 | 1297 | 0.010 |
Why?
|
Virus Cultivation | 1 | 1970 | 88 | 0.010 |
Why?
|
Absorption | 1 | 1970 | 242 | 0.010 |
Why?
|
Methods | 1 | 1970 | 1052 | 0.010 |
Why?
|
Immune Sera | 1 | 1970 | 601 | 0.010 |
Why?
|
Culture Techniques | 1 | 1970 | 515 | 0.000 |
Why?
|
Haplorhini | 1 | 1970 | 520 | 0.000 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 894 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5783 | 0.000 |
Why?
|
Guinea Pigs | 1 | 1970 | 1300 | 0.000 |
Why?
|
Neutralization Tests | 1 | 1970 | 735 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1997 | 6069 | 0.000 |
Why?
|
Databases, Factual | 1 | 2002 | 8067 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9601 | 0.000 |
Why?
|
Diet | 1 | 2002 | 8086 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2001 | 15880 | 0.000 |
Why?
|
Respiratory Tract Infections | 1 | 1970 | 1008 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36532 | 0.000 |
Why?
|
Rats | 1 | 1997 | 23707 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2001 | 15747 | 0.000 |
Why?
|
Middle Aged | 2 | 2004 | 223004 | 0.000 |
Why?
|
Kidney | 1 | 1970 | 7066 | 0.000 |
Why?
|